Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure - Heymans, S; Luttun, A; Nuyens, D; Theilmeier, G; Creemers, E; Moons, L; Dyspersin, GD; Cleutjens, JPM; Shipley, M; Angellillo, A; Levi, M; Nübe, O; Baker, A; Keshet, E; Lupu, F; Herbert, J-M; Smiths, FJM; Shapiro, SD; Baes, M; Borgers, M; Collen, D; Daemen, MJAP; Carmeliet, P (Nature Med, 1999)